Exact Sciences Corp specializes in cancer screening and diagnostic tests, offering innovative solutions like Cologuard, a non-invasive test for colorectal cancer detection. Beyond colorectal health, it provides Oncotype DX tests for breast and colon cancer recurrence, and the OncoExTra Test for advanced cancers. The company is also involved in COVID-19 testing and is working on developing new blood and fluid-based tests for cancer detection. Founded in 1995 and based in Madison, Wisconsin, Exact Sciences continues to expand its diagnostic portfolio through partnerships with leading research institutions.
Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from the prior quarterly rate. For income investors evaluating this healthcare giant’s dividend…
Pre-Market Stock Futures: Futures are trading dramatically lower as we start the holiday-shortened trading week, following yesterday’s MLK remembrance day. The futures downdraft this morning is being attributed to President Trump’s threat…
Pre-Market Stock Futures: The futures are lower on Tuesday after traders kicked off the holiday-shortened trading week with a massive Monday rally, with all major indices finishing the day higher. A combination…
Pre-Market Stock Futures: The shortened holiday week is here, and the futures are trading higher this morning. Most traders and investors are returning with a severe case of whiplash after the stock…
Pre-Market Stock Futures: The futures are trading higher as we get ready to close out a volatility-filled week that saw a massive roller coaster ride on Thursday after NVIDIA Corp. (NASDAQ: NVDA…
Alphabet (NASDAQ:GOOG | GOOG Price Prediction)(NASDAQ:GOOGL) dominates the search engine market with a greater than 90% share, powering billions of daily queries through Google Search. Yet its growth extends beyond that core…
24/7 Wall Street Insights Early cancer detection is the first line of defense in preventing the disease’s progression and reducing fatalities. Wall Street analysts are unanimously bullish on Exact Sciences’ stock, with…
John Seetoo Analysts' first ratings changes for 2024 include some deletions from a top buy list and a downgrade for Apple.
Wednesday's top analyst upgrades and downgrades included Amazon.com, Arm, Corning, Dollar General, Electronic Arts, Estee Lauder, Juniper Networks, Next Era Energy Partners, Realty Income, Rivian Automotive, Sabra Healthcare REIT and Starwood Property…
Friday's top analyst upgrades and downgrades included Agilent, Boeing, General Electric, Lockheed Martin, Meta Platforms, Micron Technology, Redfin, Salesforce, Trade Desk, Unity Software and Workday.
For aggressive growth investors with plenty of risk tolerance, the time to buy these five top stocks from Cathie Wood's ARK Innovation ETF may be now, as they could see stellar growth…
For aggressive growth investors with ample risk tolerance and a long-term horizon, these five Cathie Woods ARK Innovation ETF holdings are almost guaranteed winners now and could provide some huge gains in…
Thursday's top analyst upgrades and downgrades included Airbnb, Alcon, Antero Midstream, Exact Sciences, GitLab, GlobalFoundries, Halozyme Therapeutics, Lumentum, Nektar Therapeutics, PayPal and Southern Copper.
Monday's top analyst upgrades and downgrades included Apple, Atlassian, Block, CF Industries, Comerica, DraftKings, Exact Sciences, Global Payments, Kellogg, Mobileye Global, Shopify, VFC and Zions Bancorp.
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Asana, Etsy, Exact Sciences, Guardant Health, Hilton Worldwide, Meta Platforms, MongoDB, Salesforce, ServiceNow, Sysco and Teladoc Health.
